NO20004873D0 - Terapeutiske anvendelser av modne Flint (mFlint) polypeptider eller OPG3, et medlem av TNF-reseptor-superfamilien - Google Patents

Terapeutiske anvendelser av modne Flint (mFlint) polypeptider eller OPG3, et medlem av TNF-reseptor-superfamilien

Info

Publication number
NO20004873D0
NO20004873D0 NO20004873A NO20004873A NO20004873D0 NO 20004873 D0 NO20004873 D0 NO 20004873D0 NO 20004873 A NO20004873 A NO 20004873A NO 20004873 A NO20004873 A NO 20004873A NO 20004873 D0 NO20004873 D0 NO 20004873D0
Authority
NO
Norway
Prior art keywords
mflint
opg3
polypeptides
therapeutic applications
tnf receptor
Prior art date
Application number
NO20004873A
Other languages
English (en)
Other versions
NO20004873L (no
Inventor
Thomas Frank Bumol
Shenshen Dou
Andrew Lawrence Glasebrook
Kenneth Elliot Gould
John Edward Hale
Josef Georg Heuer
Kwan Yuk Hui
Alexei Kharitonenkov
Jacques Mizrahi
Songqing Na
Timothy Wayne Noblitt
Charles Arthur Reidy
Ho Yeong Song
Jian Wang
Xiying Wu
Steven Harold Zuckerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20004873D0 publication Critical patent/NO20004873D0/no
Publication of NO20004873L publication Critical patent/NO20004873L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20004873A 1998-03-30 2000-09-28 Terapeutiske anvendelser av modne flint (mFLINT) polypeptider eller OPG3, et medlem av TNF reseptor superfamilien NO20004873L (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US7985698P 1998-03-30 1998-03-30
US8607498P 1998-05-20 1998-05-20
US9964398P 1998-09-09 1998-09-09
US11257798P 1998-12-17 1998-12-17
US11293398P 1998-12-18 1998-12-18
US11270398P 1998-12-18 1998-12-18
US11340798P 1998-12-22 1998-12-22
PCT/US1999/006797 WO1999050413A2 (en) 1998-03-30 1999-03-30 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY

Publications (2)

Publication Number Publication Date
NO20004873D0 true NO20004873D0 (no) 2000-09-28
NO20004873L NO20004873L (no) 2000-11-24

Family

ID=27568394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004873A NO20004873L (no) 1998-03-30 2000-09-28 Terapeutiske anvendelser av modne flint (mFLINT) polypeptider eller OPG3, et medlem av TNF reseptor superfamilien

Country Status (16)

Country Link
US (1) US20040167074A1 (no)
JP (1) JP2002512006A (no)
KR (1) KR20010042364A (no)
CN (1) CN1303429A (no)
AU (1) AU3369199A (no)
BR (1) BR9909328A (no)
CA (1) CA2324517A1 (no)
CZ (1) CZ20003433A3 (no)
EA (1) EA200001004A1 (no)
HU (1) HUP0102067A2 (no)
ID (1) ID27820A (no)
IL (1) IL138626A0 (no)
NO (1) NO20004873L (no)
PL (1) PL343847A1 (no)
TR (1) TR200002824T2 (no)
WO (1) WO1999050413A2 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
CN1247567A (zh) 1997-01-14 2000-03-15 人体基因组科学有限公司 肿瘤坏死因子受体6α和6β
IL134578A0 (en) 1997-09-18 2001-04-30 Genentech Inc DcR3 POLYPEPTIDE, A TNFR HOMOLOG
EP1140138A2 (en) * 1998-12-22 2001-10-10 Eli Lilly And Company Therapeutic applications of flint polypeptides
AU3739500A (en) * 1999-03-30 2000-10-16 Eli Lilly And Company Protease resistant flint analogs
US6627199B1 (en) 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
AU783682B2 (en) 1999-08-04 2005-11-24 Amgen, Inc. Fhm, a novel member of the TNF ligand supergene family
WO2001010908A1 (en) * 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
AU7053000A (en) * 1999-09-10 2001-04-10 Eli Lilly And Company Flint compounds and formulations thereof
EP1225908A2 (en) * 1999-10-20 2002-07-31 Eli Lilly And Company Therapeutic applications of flint polypeptides
AU1915201A (en) * 1999-12-07 2001-06-18 Eli Lilly And Company Improving stability of flint through o-linked glycosylation
EP1322667A4 (en) * 2000-08-25 2004-08-18 Human Genome Sciences Inc TUMOR NECROSIS FACTOR RECEPTORS 6-ALPHA AND 6-BETA
US20040058367A1 (en) * 2001-02-23 2004-03-25 Hideki Matsui Casoase 3 inhibitors
WO2004085479A2 (en) 2003-03-26 2004-10-07 Apogenix Gmbh Treatment of viral infections
US20080293631A1 (en) * 2005-01-07 2008-11-27 Christopher John Jackson Treatment for Autoimmune and Inflammatory Conditions
PL2101877T3 (pl) 2006-12-28 2013-11-29 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Neutralizacja aktywności cd95 blokuje inwazję komórek glejaka in vivo
EP2318441A2 (en) * 2008-07-14 2011-05-11 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Use of cd95 inhibitors for the treatment of inflammatory disorders
CN102671186B (zh) * 2011-09-19 2014-08-06 上海市肿瘤研究所 促造血的药物组合物及其应用
PT2874659T (pt) 2012-07-18 2016-09-19 Apogenix Ag Inibidores da via de sinalização de cd95 para tratamento de smd
EP3076179A1 (en) 2015-03-30 2016-10-05 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Diagnosis and treatment of low grade gliomas
CN108463236A (zh) * 2015-12-18 2018-08-28 泰伦基国际有限公司 一种预防或治疗放射性和化学性损伤的方法
TWI623321B (zh) 2015-12-18 2018-05-11 Talengen Institute Of Life Sciences Co Ltd Method for preventing and treating cervical erosion
KR20220002336A (ko) 2019-03-29 2022-01-06 미스트 쎄라퓨틱스, 엘엘씨 T 세포 치료제를 제조하기 위한 생체외 방법 및 관련 조성물 및 방법
IL293350A (en) 2019-11-27 2022-07-01 Myst Therapeutics Llc A method for producing tumor-reactive t cells using modulatory substances
JP2023516636A (ja) 2020-02-27 2023-04-20 ミスト セラピューティクス リミテッド ライアビリティ カンパニー 腫瘍反応性ｔ細胞のエクスビボ富化および増大のための方法ならびに関連するその組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1247567A (zh) * 1997-01-14 2000-03-15 人体基因组科学有限公司 肿瘤坏死因子受体6α和6β
US5885800A (en) * 1997-02-04 1999-03-23 Smithkline Beecham Corporation DNA encoding tumor necrosis related receptor, TR4
WO1999004001A1 (en) * 1997-07-21 1999-01-28 Zymogenetics, Inc. Tumor necrosis factor receptor ztnfr-5
AU8767698A (en) * 1997-08-06 1999-03-01 Procter & Gamble Company, The Novel orphan receptor
IL134578A0 (en) * 1997-09-18 2001-04-30 Genentech Inc DcR3 POLYPEPTIDE, A TNFR HOMOLOG
WO1999026977A1 (en) * 1997-11-24 1999-06-03 Biogen, Inc. Novel receptors opg-2

Also Published As

Publication number Publication date
IL138626A0 (en) 2001-10-31
WO1999050413A2 (en) 1999-10-07
NO20004873L (no) 2000-11-24
ID27820A (id) 2001-04-26
CN1303429A (zh) 2001-07-11
BR9909328A (pt) 2000-12-12
KR20010042364A (ko) 2001-05-25
HUP0102067A2 (hu) 2001-10-28
CZ20003433A3 (cs) 2001-10-17
CA2324517A1 (en) 1999-10-07
JP2002512006A (ja) 2002-04-23
AU3369199A (en) 1999-10-18
US20040167074A1 (en) 2004-08-26
WO1999050413A3 (en) 1999-12-02
EA200001004A1 (ru) 2001-06-25
PL343847A1 (en) 2001-09-10
TR200002824T2 (tr) 2000-12-21

Similar Documents

Publication Publication Date Title
NO20004873D0 (no) Terapeutiske anvendelser av modne Flint (mFlint) polypeptider eller OPG3, et medlem av TNF-reseptor-superfamilien
ATA904399A (de) Adenosin a3-rezeptor-modulatoren
DK0969835T3 (da) Anvendelse af centrale cannabinoidreceptorantagonister til regulering af velsmag
ID19623A (id) Antagonis reseptor vitronektin
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
DE69820677D1 (de) Mikrokapseln mit einfach einstellbarer abgaberate
DE69610696D1 (de) Thermisch verbundener virussperrender verbundwerkstoff
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
FI972292A0 (fi) Administrering av diabetes
DK0816065T3 (da) Keramisk struktur
DE69803087D1 (de) Integrierte einzelchip dualmode raidsteuerung
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
DE69822781D1 (de) Keramikverstärkte Struktur
ID24162A (id) Antagonis-antagonis reseptor vitronektin
ATE348836T1 (de) Neue 3,6-hemiketale der 9a-azalidklasse
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
DK1115862T3 (da) Cytokinreceptor Zalpha11
DE69826316D1 (de) Hitzebeständige verbundplatte
NO994524L (no) Modulatorer av funksjonen til reseptorene til TNF/NGF-reseptorfamilien
EP0870198A4 (en) RECOMBINANT C140 RECEPTOR, ITS AGONISTS AND ANTAGONISTS, AND NUCLEIC ACIDS ENCODING THE RECEPTOR
DE29708881U1 (de) Imprägnierte Keramiksteigleitung
PT964867E (pt) Antagonistas da taquicinima
FI920987A0 (fi) Interleukin-4-receptor.
AU2930099A (en) Receptor from the superfamily of tnt-receptors from the human lung
DE59705379D1 (de) Glassteinelement der Feuerwiderstandsklassen F